XEN Gel Stent

Allergan

The XEN Gel Stent is a 6-mm gel stent designed to be implanted through a small corneal incision to create a new pathway for aqueous flow from the anterior chamber to the subconjunctival space. The stent, which swells slightly and becomes flexible when hydrated, creates a permanent channel for aqueous outflow and overtime creates a low-lying bleb.

At-a-Glance
  • Material: Gelatin, cross-linked with glutaraldehyde
  • Injected through a 27-gauge, double-beveled needle

Details

FDA

Yes

CE Mark

Yes

Classification

Ab interno

Indication

For the management of refractory glaucomas, including cases where previous surgical treatment has failed, cases of primary open-angle glaucoma, and pseudoexfoliative or pigmentary glaucoma with open angles that are unresponsive to maximum tolerated medical therapy.

Mechanism of Action

Not specified

Usage

Treatment of mild to severe glaucoma during cataract surgery or as a stand-alone procedure as indicated

From Your Peers

On the Front Lines of MIGS

READ ARTICLE »

MIGS: A Crash Course

READ ARTICLE »

MIGS: The New Glaucoma Paradigm

READ ARTICLE »

Show More

Company Information

Contact the company for additional information, availability, or pricing:

Allergan

allergan.com

5 Giralda Farms

Madison, NJ 07940